Tivicay (dolutegravir) Tablets 50 mg, 30 Tablet Bottles, Rx Only. Manufactured for: ViiV Health, TRP, NC 27709; by: GlaxoSmithKline, Research Triangle Park, NC 27709. Made in Japan. NDC 49702-228-13
Published April 9, 2014 · Recall initiated: February 11, 2014
Summary
FDA records drug Class III recall D-1185-2014, published April 9, 2014 and initiated February 11, 2014. Recalling firm: Viiv Healthcare Company; Status: Terminated; Reported quantity: 1,056 bottles; Lot: Lot #: 3ZP2210 Sub-lot A, Expiry: 10/15. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross Contamination with Other Products: Product contains Promacta (eltrombopag).
What to do
Voluntary: Firm initiated · Letter
Get an email if TIVICAY has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TIVICAY
- Manufacturer
- Viiv Healthcare Company
- Distributor
- Nationwide including Puerto Rico
- UPC
- 0349702227132
- Lot
- Lot #: 3ZP2210 Sub-lot A, Expiry: 10/15
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottleJune 12, 2024
- FDATivicay (dolutegravir) Tablets 50 mg, 30-count Bottle, Rx Only, Manufactured for: ViiV Healthcare RTP, NCJune 1, 2022
- FDADuloxetine Delayed-Release Capsules, USP, 60 mg, Rx Only, 30 Capsules per Bottle, Manufactured in Israel by:April 9, 2014
- FDASuprax, Cefixime for Oral Suspension USP 500 mg/5 ml, 10mL (when reconstituted), Rx only, Manufactured forApril 9, 2014
- FDADuloxetine Delayed-Release Capsules, USP, 30 mg, Rx Only, 30 Capsules per Bottle, Manufactured in Israel by:April 9, 2014
- FDASuprax, Cefixime for Oral Suspension USP, 500 mg/5 ml, 20 mL (when reconstituted), Rx only, Manufactured forApril 9, 2014
Questions about this recall
Was Tivicay (dolutegravir) Tablets 50 mg, 30 Tablet Bottles, Rx Only. Manufactured for: ViiV Health, TRP, NC 27709; by: GlaxoSmithKline, Research Triangle Park, NC 27709. Made in Japan. NDC 49702-228-13 recalled?
Yes. FDA published recall D-1185-2014 on April 9, 2014. Reported hazard: Cross Contamination with Other Products: Product contains Promacta (eltrombopag).
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TIVICAY. UPC: 0349702227132.